Company Search:
Advanced Search
Sponsored Links
Exelixis, Inc. Company Snapshot
Exelixis, Inc. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Exelixis with three other companies in this sector in UNITED STATES : Medpace Holdings Inc (2019 sales of $860.97 million of which 100% was SERVICES-COMMERCIAL PHYSICAL & BIOLOGICA), Galapagos NV ($1.00 billion of which 93% was R&D), and Exact Sciences Corporation ($876.29 million of which 100% was License fees).

Sales Analysis. Exelixis reported sales of $967.78 million for the year ending December of 2019. This represents an increase of 13.3% versus 2018, when the company's sales were $853.83 million. Sales at Exelixis have increased during each of the previous five years (and since 2014, sales have increased a total of 3,754%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Exelixis, Inc.
  Stock Performance Chart for Exelixis, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): 24.62
(Figures in U.S. Dollars)
1 Week -4.4%   13 Weeks -7.2%  
4 Weeks 16.7%   52 Weeks 20.9%  
Exelixis, Inc. Key Data:
  Ticker: EXEL Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Commercial Physical Research
  2019 Sales 967,775,000
(Year Ending Jan 2020).
Employees: 617
  Currency: U.S. Dollars Market Cap: 7,528,303,600
  Fiscal Yr Ends: December Shares Outstanding: 305,780,000
  Share Type: Common Closely Held Shares: 9,261,162
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.